Home/Filings/4/0000930413-18-002502
4//SEC Filing

O'Brien James Michael 4

Accession 0000930413-18-002502

CIK 0000316253other

Filed

Aug 1, 8:00 PM ET

Accepted

Aug 2, 7:06 PM ET

Size

5.7 KB

Accession

0000930413-18-002502

Insider Transaction Report

Form 4
Period: 2018-07-31
O'Brien James Michael
SVP of Finance
Transactions
  • Award

    Stock Option (to acquire common stock)

    2018-07-31+35,00023,666 total
    Exercise: $4.42From: 2019-08-01Exp: 2023-07-31Common Stock (35,000 underlying)
Footnotes (2)
  • [F1]The Reporting Person was granted 35,000 stock options. The options have a five-year term and shall vest in three equal annual tranches, beginning August 1, 2019.
  • [F2]Does not include 4,000 Performance Stock Units granted to the Reporting Person on July 31, 2018, which will vest, if at all, based upon (i) achievement of average revenue growth and adjusted EBITDA growth goals on July 31, 2021, and (ii) the continued service of the Reporting Person through July 31, 2021.

Documents

1 file

Issuer

ENZO BIOCHEM INC

CIK 0000316253

Entity typeother

Related Parties

1
  • filerCIK 0001632111

Filing Metadata

Form type
4
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 7:06 PM ET
Size
5.7 KB